$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is trametinib covered by medical insurance? Analysis of anti-cancer drug reimbursement policies that patients are concerned about
2026-02-01 22:25:32
Check Details
Does fostatinib cause weight gain?
2026-02-01 22:25:32
Check Details
Analysis of side effects of dabrafenib/dabrafenib: What should patients pay attention to when taking the drug?
2026-02-01 22:25:32
Check Details
Can cabozantinib be reimbursed by medical insurance? Financial Burden and Solutions for Patients’ Medication
2026-02-01 22:25:32
Check Details
None
2026-02-01 22:25:32
Check Details
Eltrombopag/eltrombopag in the treatment of aplastic anemia: How long does it take to be effective?
2026-02-01 22:25:32
Check Details
An in-depth analysis of the clinical value of the innovative platelet-generating drugs Ropremilast/Romigrastim
2026-02-01 22:25:32
Check Details
Detailed instructions for the anticancer drug midostaurin: indications, usage, dosage and precautions
2026-02-01 22:25:32
Check Details
Analysis of the side effects of the milk-reducing drug cabergoline: What issues should breastfeeding women pay attention to?
2026-02-01 22:25:32
Check Details
Analysis of the marketing status of molotinib/mometinib in China: key information patients need to know
2026-02-01 22:25:32
Check Details
A must-read for HIV-infected people: Scientific response strategies for missing doses of Bituvi/Bikernoprenol tablets for 24 hours
2026-02-01 22:25:32
Check Details
Detailed explanation of the indications of trametinib: Which patients can benefit from this targeted drug?
2026-02-01 22:25:32
Check Details
1
2
...
1290
1291
1292
1293
1294
1295
1296
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets
2
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship
3
Tyrosine Kinase and JAK Inhibitors May Increase Keratinocyte Carcinoma Risk: New Research Reveals Drug Safety Findings
4
CLISGen Database: A New Tool for Cell Line Selection in Cancer Genetic Variation Research
5
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
6
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
7
User Agreement
8
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
9
What is the most important information I should know about WELIREG?
10
How to take and store WELIREG
11
How to take TRUSELTIQ correctly
12
How to deal with LONSURF side effects (1)